CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Phonak Hearing Aiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05372094
NCT05372094N/ACompleted

Noise Reduction Preferences in Teenagers and Pre-teens

Sonova AG·interventional·Posted May 12, 2022·Updated Jan 9, 2024

In Brief

A clinical study evaluating Phonak Hearing Aid for Hearing Loss. Completed, enrolled 18 participants across 1 site.

Detailed Summary

Noise reduction preferences and blue tooth access to hearing aid streaming features will be evaluated in experienced hearing aid users age 10-17.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 12, 2022
Enrollment StartFeb 23, 2023
Primary CompletionSep 30, 2023
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.1 years ago

Interventions

Phonak Hearing Aiddevice

Commercially available hearing aid with various noise reduction strengths